Youssef Razouqi, PhD
Area of Focus
- Alzheimer's disease
- Genetics of Parkinson’s
- Genomics
- Genetics
- Biomarker
- Dementia
- Genetic risk
- Database and clinical information management
- Neurogenetics
- Polygenic Risk Score (PRS)
Biography
Youssef Razouqi is a dedicated neuroscientist and bioinformatics researcher specializing in the study of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s, with a focus on underrepresented populations such as Morocco. His academic journey began with a bachelor’s degree in biomedical sciences from Soultane Moulay Slimane University, where his thesis explored dietary patterns and biochemical markers in diabetic patients, showcasing his early interest in public health. He then pursued a Master’s degree in Neurocognition and Population Health at Ibn Tofail University, where he investigated **APOE** polymorphisms in Alzheimer’s patients, applying advanced molecular biology techniques like PCR and Sanger sequencing. Currently, Youssef is a PhD candidate in Neurosciences and Bioinformatics, conducting pioneering research on Parkinson’s disease at the University Mohammed VI of Sciences and Health in Casablanca. His work involves targets using multi-omics approaches.
In addition His research outputs include significant contributions to Alzheimer’s genetics, resulting in a first-author publication in Alzheimer Disease & Associated Disorders and collaborative works addressing vaccine hesitancy and public health during the COVID-19 pandemic. His scientific rigor is complemented by his teaching role as a psychology instructor, where he mentors aspiring healthcare professionals. Youssef has also participated in prestigious training programs such as the Bioscience School in London and the IBRO-MENA workshop, enhancing his expertise in neuroscience and computational biology. His dedication to advancing neuroscience research in Africa and bridging gaps in knowledge through collaborative efforts reflects his commitment to improving diagnostic and therapeutic strategies for neurodegenerative diseases. Through his leadership, technical expertise, and vision, Youssef exemplifies the integration of science and societal impact.